Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

12 Companies to Watch in the Contract In Vitro Diagnostics Market: Report

Kalorama Information
Posted on: 01 May 18
12 Companies to Watch in the Contract In Vitro Diagnostics Market: Report

PR Newswire

ROCKVILLE, Md., May 1, 2018

ROCKVILLE, Md., May 1, 2018 /PRNewswire/ -- Kalorama Information said that the global market for IVD products manufactured by contract organizations was an estimated $12.2 billion in 2017.  That's the conclusion of Kalorama Information's new report Contract Manufacturing in IVD: Market Analysis.   Among large-selling products included in this amount are blood glucose test strips, purified monoclonal antibodies for immunoassay and molecular procedures, finished ELISA (enzyme-linked immunosorbent assays) test kits, lyophilized clinical chemistry calibrators, benchtop clinical chemistry and immunoassay analyzers, antibiotic susceptibility microplates, chromogenic media plates, handheld blood glucose meters, handheld coagulation instruments, amplified DNA probes, RNA assays, coated microarray slides, and other products.  The report said many contract IVD manufacturers also provide complete packaging service as an added convenience to customers.

"Unlike other medical device segments, the IVD industry has been slow to transfer manufacturing responsibilities to outside contractors in the developing countries," said Bruce Carlson, Publisher of Kalorama Information.  "Over the next several years, IVD companies are expected to broaden the use of contract manufacturing to strengthen competitive positions." 

In all major product groups and technology classes, contract manufactured IVD goods will generate above average sales growth globally. This trend will reflect the several advantages typically provided by outside contractors, including:

  • access to proprietary production processes and technologies

  • reduction in time required to gain regulatory approvals for plant validation and product marketing

  • alleviation or prevention of production capacity shortages

  • the freeing up of staff to focus on higher strategic priorities

  • the penetration of new markets without the need for capital investment

  • enhanced cost efficiencies in raw material selection and other production inputs

The report said that the following are among the top competitors in the industry.  Affinity Biologicals, Inc.,  Biokit S.A., Cenogenics Corporation, EKF Diagnostic Holdings plc.  Guilin Royalyze Medical Co. Ltd, IDxDI, Meridian Life Science Inc., MilliporeSigma, Polymed Therapeutics, Inc., Promega Corporation, Savyon Diagnostics and Sekisui Diagnostics LLC

More information can be found in Kalorama Information's report.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.  

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website: https://www.kaloramainformation.com/.   

Press Contact:                                                        
Bruce Carlson
212 807 2262
bcarlson@marketresearch.com

View original content with multimedia:http://www.prnewswire.com/news-releases/12-companies-to-watch-in-the-contract-in-vitro-diagnostics-market-report-300635533.html

SOURCE Kalorama Information

PR Newswire
www.prnewswire.com

Last updated on: 01/05/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.